<DOC>
	<DOCNO>NCT00002174</DOCNO>
	<brief_summary>To determine Thalidomide modulate production HIV-suppressor factor ( MIP-1 alpha , MIP-1 beta , Rantes ) TH1 type cytokine ( IL-12 INF-gamma ) HIV-infected patient alters viral load .</brief_summary>
	<brief_title>Further Evaluation Thalidomide 's Ability Potentiate Immune Response HIV-Infected Patients</brief_title>
	<detailed_description>Patients divide , 5 per group , Groups I , II , III IV . Groups I II include patient decide take anti-retro viral drug . Groups III IV include patient receive type antiretroviral drug . Patients group I III receive thalidomide patient group II IV receive placebo . The placebo capsule color thalidomide capsule contain glucose powder . Patients ingest one capsule thalidomide 9 PM daily day 0 , 1 , 2 , 3 , 4 , 5 6 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4+ cell count &gt; = 200/microliter &gt; 14 % CD4+ cell peripheral blood . Willingness commit study duration agree abide time table entry study , ingestion thalidomide followup . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Fertile female . Patients participate clinical study involve new drug device within last 2 month period time equivalent seven time half life study drug , whichever longer . Patients follow prior condition exclude : HIV relate preexist peripheral neuropathy . Prior Medication : Excluded : Patients use systemic steroidal anti inflammatory drug pentoxifylline within 10 day dose thalidomide . Required : 10 20 patient must antiretroviral therapy 10 subject decide antiretroviral drug prior enrollment study plan start treatment study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 1997</verification_date>
	<keyword>Adjuvants , Immunologic</keyword>
	<keyword>Thalidomide</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Viral Load</keyword>
</DOC>